CHANGES IN FIBRINOLYTIC CAPACITY AND LIPOPROTEIN PATTERN DURING LONG-TERM TREATMENT WITH WARFARIN

被引:1
作者
ARNESEN, H
SMITH, P
ASPELUND, EB
机构
关键词
D O I
10.1016/0049-3848(86)90138-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:229 / 233
页数:5
相关论文
共 13 条
[1]  
ANDERSEN P, 1981, ACTA MED SCAND, V209, P199
[2]  
ARNESEN H, 1983, SCAND J HAEMATOL, V30, P43
[3]   SERUM GLUCOSE-LEVELS DURING LONG-TERM OBSERVATION OF TREATED AND UNTREATED MEN WITH MILD HYPERTENSION - THE OSLO STUDY [J].
HELGELAND, A ;
LEREN, P ;
FOSS, OP ;
HJERMANN, I ;
HOLME, I ;
LUNDLARSEN, PG .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (05) :802-805
[4]  
KAMATH VR, 1969, LANCET, V1, P1025
[5]  
KJELDSEN SE, 1982, SCAND J CLIN LAB INV, V42, P449
[6]   VARIATION IN FIBRINOLYTIC ACTIVITY AFTER ACUTE MYOCARDIAL INFARCTION AND AFTER THE ADMINISTRATION OF ORAL ANTICOAGULANT DRUGS AND INTRAVENOUS HEPARIN [J].
LACKNER, H ;
MERSKEY, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1960, 6 (04) :402-413
[7]   EFFECTS OF ANTIHYPERTENSIVE THERAPY ON PLASMA-LIPIDS AND LIPOPROTEINS IN THE MULTIPLE RISK FACTOR INTERVENTION TRIAL [J].
LASSER, NL ;
GRANDITS, G ;
CAGGIULA, AW ;
CUTLER, JA ;
GRIMM, RH ;
KULLER, LH ;
SHERWIN, RW ;
STAMLER, J .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (2A) :52-66
[8]  
LEREN P, 1982, LANCET, V2, P4
[9]  
NORDBY E, 1980, SCAND J HAEMATOL, V25, P407
[10]  
SIMPSON HCR, 1983, LANCET, V1, P786